India Today on MSN2h
India approves living drug to treat blood cancer: All about Qartemi and how it works
The second indigenous CAR-T cell therapy, Qartemi, has been approved by India's drug regulator. Qartemi is a "living drug" ...
Daily1d
Sanofi Healthcare India gets CDSCO Panel nod to study Nirsevimab
New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...
ThePrint4d
2nd ‘living drug’ against blood cancer gets regulatory nod. All about Qartemi, made in India
Therapy will cost Rs 35 to 50 lakh. India sees around 1.20 lakh new blood cancer cases and over 70,000 deaths annually from ...
Budget 2025: Pharma industry lays out a plan to curb Chinese dependence
India's pharmaceutical industry holds immense promise, but experts and stakeholders assert that to unlock its full potential, ...
ICMR and CDSCO develop framework for validation of pathogen identification and antimicrobial susceptibility testing
Inability to provide accurate and timely diagnosis is one of the major contributors to the misuse and overuse of ...
Pharmabiz4d
CDSCO releases guidance document to evaluate performance and efficacy of IVDs to combat AMR
CDSCO releases guidance document to evaluate performance and efficacy of IVDs to combat AMR: Gireesh Babu, New Delhi Monday, January 20, 2025, 08:00 Hrs [IST] The Central Drugs St ...
devdiscourse5d
India Bans Import of Refurbished Medical Devices to Boost Local Industry
The Central Drugs Standard Control Organisation (CDSCO) has banned the import of refurbished medical devices, reinforcing India’s commitment to patient safety and strengthening the local industry's ...
India Today10d
How Ozempic, Zepbound, and Mounjaro will transform India's weight loss market
The proportion of obese Indians has risen from 25 per cent in 2013 to 40 per cent in 2023, highlighting the need for ...
SS Innovations International Performs World's First Robotic Cardiac Telesurgeries with its SSi Mantra 3
A Robotic-Assisted Internal Mammary Artery Harvesting Telesurgery procedure was successfully completed in 58 minutes.The world’s first Robotic ...
Daily11d
CDSCO Panel approves Dr Reddys proposal to increase patients from 241 to 265 in India for anticancer drug Nivolumab study
New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...
Medtech industry expects regulatory body to reclassify more medical devices
Industry experts expect that the Central Drugs Standard Control Organisation (CDSCO) could reclassify more medical devices ...
National Journal15d
FDA’s Lengthy Drug Approval Process in Twelve Steps
You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.